Band 8+: The chart below shows the percentage of a drug company's total sales, by region, from 2002 to 2006. Summarize the information by selecting and reporting the main features, and make comparisons where relevant.

The bar chart illustrates the total revenue of remedy companies by percentage in three specific regions between 2002 and 2006.

Overall, it is noticeable that American and European companies experienced a downward trend, while those in Asia demonstrated the opposite tendency. Moreover, at the beginning, Asia had the lowest proportion among the three regions, but by the end of the period, it ranked first.

In 2002, American companies accounted for 41%, which was the highest rate for that year. This figure gradually declined to 27% over the next two years, followed by a slight increase to 30% in 2006. The proportion of companies in Europe was 34% at the beginning, and in the following year, they caught up and equaled their American counterparts, both at 35%. In 2004, European companies experienced a negligible rise to 38%, but by the end of the period, their percentage dropped back to match the Americans at 30%. In contrast, the percentage of Asian companies steadily increased, starting at 25% and rising step-by-step to 35% in 2004. Furthermore, it continued to climb to 40% by the end of the examined period in 2006.